gvtcx

Thrombotic Thrombocytopenic Pupura (TTP) - DAP A

NHS England Published 29 Apr 2026 Find a Tender

key details

Statuscomplete
Category (CPV) 85100000
Procedurelimited
OCIDocds-h6vhtk-068df7

Awards (10)

This procurement was awarded to 10 suppliers. Values shown are per-award; the notice total is ·.

description

Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder with rapid onset, that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. <br/>The condition can be difficult to diagnose because initial presentation can be non-specific, and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects adults. Children are treated in paediatric haematology centres with support from the adult specialists. Specialist aftercare is also required. Services are required to have a programme of outreach and education to improve timely diagnosis and referral. There is a small population with a congenital form of the disease who require ongoing treatment and monitoring. <br/>Patients need to be able to access specialist care with 24/7 access to apheresis and a specialist team. Patients need to start in treatment within 4/8 hours of a referral to the specialist centre.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
29 Apr 2026 Contract award notice (F03) Earlier regulations 039184-2026

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.